Matches in DBpedia 2016-04 for { <http://dbpedia.org/resource/Delcath_Systems> ?p ?o }
Showing triples 1 to 65 of
65
with 100 triples per page.
- Delcath_Systems abstract "Delcath Systems, Inc. Delcath Systems, Inc. (NASDAQ: DCTH) is a publicly-traded specialty pharmaceutical and medical device company that develops percutaneous perfusion technologies for the targeted administration of high-dose chemotherapeutic agents to specific organs or regions of the body. Based in Queensbury, New York, the company has an intellectual property portfolio consisting of 28 patents worldwide. Delcath's Percutaneous Hepatic Perfusion (PHP) is currently undergoing Phase II and Phase III trials against tumors in the liver. Delcath has a Cooperative Research and Development Agreement (CRADA) with the National Cancer Institute and has received Fast Track and a Special Protocol Assessment from the Food and Drug Administration for its use of melphalan in treating unresectable liver tumors. PHP, also known as the Delcath System, is tested for the treatment of metastatic melanoma in the liver and for primary liver cancer and metastatic hepatic malignancies from neuroendocrine cancers and adenocarcinomas, as well as patients with melanoma who previously received isolated perfusion. Chemotherapy is usually delivered intravenously, although a number of agents can be administered orally (e.g. specialty drugs, melphalan (trade name Alkeran), busulfan, capecitabine).".
- Delcath_Systems wikiPageExternalLink 20070530006062.html?.v=1.
- Delcath_Systems wikiPageExternalLink www.delcath.com.
- Delcath_Systems wikiPageID "12293417".
- Delcath_Systems wikiPageLength "4217".
- Delcath_Systems wikiPageOutDegree "34".
- Delcath_Systems wikiPageRevisionID "685346351".
- Delcath_Systems wikiPageWikiLink Adenocarcinoma.
- Delcath_Systems wikiPageWikiLink Busulfan.
- Delcath_Systems wikiPageWikiLink Cancer.
- Delcath_Systems wikiPageWikiLink Capecitabine.
- Delcath_Systems wikiPageWikiLink Category:Cancer_organizations_based_in_the_United_States.
- Delcath_Systems wikiPageWikiLink Category:Companies_based_in_New_York_City.
- Delcath_Systems wikiPageWikiLink Category:Companies_listed_on_NASDAQ.
- Delcath_Systems wikiPageWikiLink Category:Health_care_companies_of_the_United_States.
- Delcath_Systems wikiPageWikiLink Category:Hepatology.
- Delcath_Systems wikiPageWikiLink Category:Specialty_drugs.
- Delcath_Systems wikiPageWikiLink Chemotherapy.
- Delcath_Systems wikiPageWikiLink Clinical_trial.
- Delcath_Systems wikiPageWikiLink Cooperative_research_and_development_agreement.
- Delcath_Systems wikiPageWikiLink FDA_Fast_Track_Development_Program.
- Delcath_Systems wikiPageWikiLink FDA_Special_Protocol_Assessment.
- Delcath_Systems wikiPageWikiLink Food_and_Drug_Administration.
- Delcath_Systems wikiPageWikiLink Hepatocellular_carcinoma.
- Delcath_Systems wikiPageWikiLink Intellectual_property.
- Delcath_Systems wikiPageWikiLink Intravenous_therapy.
- Delcath_Systems wikiPageWikiLink Liver.
- Delcath_Systems wikiPageWikiLink Melanoma.
- Delcath_Systems wikiPageWikiLink Melphalan.
- Delcath_Systems wikiPageWikiLink Metastasis.
- Delcath_Systems wikiPageWikiLink National_Cancer_Institute.
- Delcath_Systems wikiPageWikiLink Neoplasm.
- Delcath_Systems wikiPageWikiLink Neuroendocrine_tumor.
- Delcath_Systems wikiPageWikiLink Patent.
- Delcath_Systems wikiPageWikiLink Percutaneous.
- Delcath_Systems wikiPageWikiLink Percutaneous_hepatic_perfusion.
- Delcath_Systems wikiPageWikiLink Queensbury,_New_York.
- Delcath_Systems wikiPageWikiLink Route_of_administration.
- Delcath_Systems wikiPageWikiLink Segmental_resection.
- Delcath_Systems wikiPageWikiLink University_of_Pittsburgh_Medical_Center.
- Delcath_Systems wikiPageWikiLinkText "Delcath Systems".
- Delcath_Systems wikiPageUsesTemplate Template:ClinicalTrialsGov.
- Delcath_Systems wikiPageUsesTemplate Template:Med-company-stub.
- Delcath_Systems wikiPageUsesTemplate Template:Oncology-stub.
- Delcath_Systems wikiPageUsesTemplate Template:Reflist.
- Delcath_Systems subject Category:Cancer_organizations_based_in_the_United_States.
- Delcath_Systems subject Category:Companies_based_in_New_York_City.
- Delcath_Systems subject Category:Companies_listed_on_NASDAQ.
- Delcath_Systems subject Category:Health_care_companies_of_the_United_States.
- Delcath_Systems subject Category:Hepatology.
- Delcath_Systems subject Category:Specialty_drugs.
- Delcath_Systems type Company.
- Delcath_Systems type Company.
- Delcath_Systems type Organization.
- Delcath_Systems type Redirect.
- Delcath_Systems type Specialty.
- Delcath_Systems type Organization.
- Delcath_Systems comment "Delcath Systems, Inc. Delcath Systems, Inc. (NASDAQ: DCTH) is a publicly-traded specialty pharmaceutical and medical device company that develops percutaneous perfusion technologies for the targeted administration of high-dose chemotherapeutic agents to specific organs or regions of the body. Based in Queensbury, New York, the company has an intellectual property portfolio consisting of 28 patents worldwide.".
- Delcath_Systems label "Delcath Systems".
- Delcath_Systems sameAs Q5253556.
- Delcath_Systems sameAs m.02vz81l.
- Delcath_Systems sameAs Q5253556.
- Delcath_Systems wasDerivedFrom Delcath_Systems?oldid=685346351.
- Delcath_Systems homepage www.delcath.com.
- Delcath_Systems isPrimaryTopicOf Delcath_Systems.